Page last updated: 2024-11-13

ac 3933

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine: a cognitive enhancer; structure in first source does not agree with name [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135418404
CHEMBL ID2107801
SCHEMBL ID677466
MeSH IDM0463178

Synonyms (24)

Synonym
ac 3933
5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-2-oxo-1,2-dihydro-1,6-naphthyridine
ac-3933 ,
219846-31-8
2g222t03ey ,
radequinil
resequinil [inn]
unii-2g222t03ey
radequinil [inn]
resequinil
sx-3933
CHEMBL2107801
ave-3933
JQOFKKWHXGQABB-UHFFFAOYSA-N
3-(5-methyl-1,2,4-oxadiazol-3-yl)-5-(3-methoxyphenyl)-1,6-naphthyridin-2(1h)-one
SCHEMBL677466
5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3-yl)-1h-1,6-naphthyridin-2-one
5-(3-methoxyphenyl)-3-(5-methyl-1,2,4-oxadiazol-3(2h)-ylidene)-1,6-naphthyridin-2(3h)-one
DTXSID60944577
Q7280124
CS-0024655
MS-25042
HY-106025
AKOS040742532
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]